Tomorrow (July 15, 2026) the landmark administrative hearing on US cannabis rescheduling will come to a close. Today (July 14),
On Monday (June 29), the most consequential hearing in the history of US cannabis policy began proceedings, as the DEA
In the weeks since cannabis under a state medical licence was moved to Schedule III, US multi-state operators (MSOs) have
As the federal campaign to clamp down on intoxicating hemp in the US rolls on, the Drug Enforcement Administration (DEA)
As the industry’s (more than justified) excitement over last week’s rescheduling announcement begins to subside, the regulatory reality is settling
After years of false starts, political delays and administrative paralysis, the United States federal government has taken its first concrete
Cannabis stocks have once again been sent flying in the wake of the latest hint of progress on cannabis rescheduling
Terrance Cole, has been confirmed as the new permanent head of the Drug Enforcement Administration (DEA), and will now be responsible for the future of the landmark cannabis rescheduling project.
The frozen US cannabis rescheduling process appears to be stuck in limbo for the foreseeable future, as the Drug Enforcement Administration’s (DEA’s) new management confirmed the process ‘remains pending’.
Cannabis rescheduling was thrown back into the spotlight last week as the new potential head of the Drug Enforcement Administration (DEA) said it would be a ‘priority’.
A coalition of pro-cannabis medical professionals has dropped its lawsuit against the Drug Enforcement Administration (DEA), clearing one of the many hurdles preventing the process from progressing.
New court documents are said to provide new evidence of the US Drug Enforcement Administration’s bias against cannabis rescheduling, a process which it is overseeing.
The US Department of Justice (DOJ) has determined that protections preventing the removal of Administrative Law Judges (ALJs) are unconstitutional and will no longer defend them in court, a move that could have significant implications for cannabis research.
Cannabis rescheduling was dealt a major blow today as it was confirmed that long-time cannabis sceptic and anti-drug veteran Derek S. Maltz has been appointed as acting administrator of the DEA.
The Drug Enforcement Administration (DEA) has come under renewed pressure to be removed from the upcoming cannabis rescheduling process amid
The Drug Enforcement Administration (DEA) has scheduled an official date for the highly anticipated public hearing on cannabis rescheduling, starting with a presentation from the government just a day after President Elect Donald Trump is sworn in.
Just days after announcing the first tranche of witnesses for the critical upcoming public hearing on cannabis rescheduling, the Drug Enforcement Administration (DEA) has postponed it until early 2025.
The US Drug Enforcement Administration (DEA) has announced the first witnesses due to attend the critical upcoming public hearing on cannabis rescheduling.
We won’t spam you
